Literature DB >> 29356560

Reply to Yanagisawa: Treatment of Pulmonary Lymphangioleiomyomatosis during Pregnancy.

Nishant Gupta1, Simon R Johnson2, Joel Moss3, Francis X McCormack4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29356560      PMCID： PMC6835069          DOI： 10.1164/rccm.201801-0043LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

Authors:  Souheil El-Chemaly; Angelo Taveira-Dasilva; Hilary J Goldberg; Elizabeth Peters; Mary Haughey; Don Bienfang; Amanda M Jones; Patricia Julien-Williams; Ye Cui; Julian A Villalba; Shefali Bagwe; Rie Maurer; Ivan O Rosas; Joel Moss; Elizabeth P Henske
Journal:  Chest       Date:  2017-02-10       Impact factor: 9.410

Review 2.  The risks of statin use in pregnancy: A systematic review.

Authors:  Dean G Karalis; Alethea N Hill; Shari Clifton; Robert A Wild
Journal:  J Clin Lipidol       Date:  2016-07-20       Impact factor: 4.766

Review 3.  Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.

Authors:  Maria-Elena Lautatzis; Dimitrios G Goulis; Maria Vrontakis
Journal:  Metabolism       Date:  2013-07-23       Impact factor: 8.694

4.  A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis.

Authors:  William Y C Chang; Jennifer L Cane; Maruti Kumaran; Sarah Lewis; Anne E Tattersfield; Simon R Johnson
Journal:  Eur Respir J       Date:  2013-12-05       Impact factor: 16.671

Review 5.  Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

Authors:  Anya Alayev; Sara Malka Berger; Marina K Holz
Journal:  Ann N Y Acad Sci       Date:  2015-07-22       Impact factor: 5.691

6.  Statins in lymphangioleiomyomatosis: a word of caution.

Authors:  S El-Chemaly; A Taveira-DaSilva; M P Stylianou; J Moss
Journal:  Eur Respir J       Date:  2009-08       Impact factor: 16.671

7.  Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Amanda M Jones; Patricia A Julien-Williams; Mario Stylianou; Joel Moss
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

8.  SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.

Authors:  Alexey Tyryshkin; Abhisek Bhattacharya; N Tony Eissa
Journal:  Cancer Res       Date:  2014-04-01       Impact factor: 12.701

9.  Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Authors:  Nishant Gupta; Geraldine A Finlay; Robert M Kotloff; Charlie Strange; Kevin C Wilson; Lisa R Young; Angelo M Taveira-DaSilva; Simon R Johnson; Vincent Cottin; Steven A Sahn; Jay H Ryu; Kuniaki Seyama; Yoshikazu Inoue; Gregory P Downey; MeiLan K Han; Thomas V Colby; Kathryn A Wikenheiser-Brokamp; Cristopher A Meyer; Karen Smith; Joel Moss; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

10.  Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.

Authors:  Chenggang Li; Po-Shun Lee; Yang Sun; Xiaoxiao Gu; Erik Zhang; Yanan Guo; Chin-Lee Wu; Neil Auricchio; Carmen Priolo; Jing Li; Alfredo Csibi; Andrey Parkhitko; Tasha Morrison; Anna Planaguma; Shamsah Kazani; Elliot Israel; Kai-Feng Xu; Elizabeth Petri Henske; John Blenis; Bruce D Levy; David Kwiatkowski; Jane J Yu
Journal:  J Exp Med       Date:  2014-01-06       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.